CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
Article in Frontiers in Pharmacology (November 2023)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
CYP2D6 pharmacogenetics and phenoconversion in personalized medicine
Article in Expert Opinion on Drug Metabolism & Toxicology (November 2022)
Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities
Article in Anti-Cancer Drugs (August 2022)